- Home
- FOSL vs GNTA Comparison
FOSL vs GNTA Comparison
Compare FOSL & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- GNTA
- Stock Information
- Founded
- FOSL 1984
- GNTA 2014
- Country
- FOSL United States
- GNTA Italy
- Employees
- FOSL N/A
- GNTA N/A
- Industry
- FOSL Consumer Specialties
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FOSL Consumer Discretionary
- GNTA Health Care
- Exchange
- FOSL Nasdaq
- GNTA Nasdaq
- Market Cap
- FOSL 112.2M
- GNTA 96.0M
- IPO Year
- FOSL 1993
- GNTA 2021
- Fundamental
- Price
- FOSL $1.85
- GNTA $5.01
- Analyst Decision
- FOSL
- GNTA Strong Buy
- Analyst Count
- FOSL 0
- GNTA 1
- Target Price
- FOSL N/A
- GNTA $25.00
- AVG Volume (30 Days)
- FOSL 2.3M
- GNTA 5.8K
- Earning Date
- FOSL 11-07-2024
- GNTA 01-01-0001
- Dividend Yield
- FOSL N/A
- GNTA N/A
- EPS Growth
- FOSL N/A
- GNTA N/A
- EPS
- FOSL N/A
- GNTA N/A
- Revenue
- FOSL $1,223,954,000.00
- GNTA N/A
- Revenue This Year
- FOSL N/A
- GNTA N/A
- Revenue Next Year
- FOSL N/A
- GNTA N/A
- P/E Ratio
- FOSL N/A
- GNTA N/A
- Revenue Growth
- FOSL N/A
- GNTA N/A
- 52 Week Low
- FOSL $0.75
- GNTA $2.20
- 52 Week High
- FOSL $2.61
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- FOSL 55.78
- GNTA 47.05
- Support Level
- FOSL $1.64
- GNTA $4.95
- Resistance Level
- FOSL $2.01
- GNTA $5.50
- Average True Range (ATR)
- FOSL 0.19
- GNTA 0.27
- MACD
- FOSL -0.03
- GNTA -0.01
- Stochastic Oscillator
- FOSL 31.82
- GNTA 45.56
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.